All included studies for CD4 T-cells (six studies) reported decreased counts in the non-survivors relative to survivors (SMD = −0.99 to −0.03) (Figure 5A and Supplementary Table 9.4), for the pairwise comparison between COVID-19 survivors and non-survivors. The gene discussed is CD4; the disease is COVID-19.